Delisting riskPopularity #4,541
IMNN · NASDAQ · Biotechnology

Imunon (IMNN)

Developing localized DNA immunotherapy for advanced ovarian cancer.

$1.42
vs last close−0.09 (−5.96%)

13F · 13D/G · Form 4

Institutions7.58%318.7K shares
23 holders · as of Jun 30, 2026
Insiders7.62%320.4K shares
10 holders · as of Sep 15, 2026
Other84.80%3.56M shares
remainder

4.20M company shares as of Sep 5, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (5.61M in the company's Sep 23, 2026 report, 4.20M elsewhere); stakes use the report.

13F · 13D/G · Form 4

HolderStakeSharesDate
Armistice Capital, LLCInstitution
3.45%144,767as of Jun 30, 2026
Stacy LindborgInsiderdirector, officer: President and CEO
2.51%105,580filed Sep 15, 2026
Michael H. TardugnoInsiderdirector, officer: Executive Chairman of Board
2.28%95,699filed Sep 15, 2026
Vanguard Capital Management LLCInstitution
1.12%46,967as of Jun 30, 2026
Douglas Vincent FallerInsiderofficer: Chief Medical Officer
0.98%41,288filed Sep 15, 2026
Riverview Capital Advisers, LLCInstitution
0.82%34,364as of Jun 30, 2026
Geode Capital Management, LLCInstitution
0.75%31,629as of Jun 30, 2026
James E. DentzerInsiderdirector
0.52%21,897filed Aug 4, 2026
Frederick J. FritzInsiderdirector
0.50%21,031filed Aug 4, 2026
Virtu Financial LLCInstitution
0.42%17,456as of Jun 30, 2026
Donald P. BraunInsiderdirector
0.37%15,499filed Aug 4, 2026
Christine A. PellizzariInsiderdirector
0.36%15,076filed Aug 4, 2026
Vanguard Fiduciary Trust CoInstitution
0.32%13,269as of Jun 30, 2026
Northern Trust CorpInstitution
0.25%10,342as of Jun 30, 2026
UBS Group AGInstitution
0.12%5,203as of Jun 30, 2026
BlackRock, Inc.Institution
0.11%4,464as of Jun 30, 2026
Tower Research Capital LLC (TRC)Institution
0.09%3,952as of Jun 30, 2026
Wells Fargo & Company/MNInstitution
0.08%3,342as of Jun 30, 2026
Susan EylwardInsiderofficer: General Counsel and Corp Sec
0.07%2,896filed Sep 1, 2026
Morgan StanleyInstitution
0.04%1,574as of Jun 30, 2026
Kimberly BraggInsiderofficer: CFO
0.03%1,360filed Jun 17, 2025
Sbi Securities Co., Ltd.Institution
0.02%1,027as of Jun 30, 2026
Barclays PLCInstitution
0.00%194as of Jun 30, 2026
JPMorgan Chase & CoInstitution
0.00%134as of Jun 30, 2026
Jeffrey Wayne ChurchInsiderofficer: CFO
0.00%26filed Jan 20, 2026

13F, as of Jun 30, 2026

23 holders · 318.7K shares · 7 new positions · 9 increased · 4 reduced · 2 closed

HolderShares% outstandingChg q/qFiled
Armistice Capital, LLC144.8K3.45%−203.6KAug 14, 2026
Vanguard Capital Management LLC47.0K1.12%−1.1KAug 13, 2026
Riverview Capital Advisers, LLC34.4K0.82%0Aug 13, 2026
Geode Capital Management, LLC31.6K0.75%−1.6KAug 12, 2026
Virtu Financial LLC17.5K0.42%+17.5KnewAug 13, 2026
Vanguard Fiduciary Trust Co13.3K0.32%0Aug 13, 2026
Northern Trust Corp10.3K0.25%+10.3KnewAug 13, 2026
UBS Group AG5.2K0.12%+4.6KAug 13, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Armistice Capital, LLC9.99%396.7K13GMay 15, 2026
Opportunity Master Fund, SPC – Segregated Master Portfolio Bincl. Capital LLC, Khatri9.90%13GNov 14, 2024

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 31, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale2,525$1.562,896
Aug 17, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale2,449$1.632,896
Aug 3, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale2,541$1.572,896
Jul 20, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale2,150$1.782,896
Jul 6, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale920$1.882,896
Jun 29, 2026
Susan Eylwardofficer: General Counsel and Corp Sec
Sale11,800$1.752,896

House and Senate disclosures

Not reported.